scPharmaceuticals, Inc.
(NASDAQ : SCPH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
0.07%140.060.6%$755.50m
PFEPfizer Inc.
0.59%43.260.9%$742.04m
MRKMerck & Co., Inc.
-0.19%70.290.6%$455.52m
ABBVAbbVie, Inc.
0.60%95.952.1%$344.71m
LLYEli Lilly and Company
0.76%106.511.0%$322.35m
BMYBristol-Myers Squibb Company
0.07%61.341.4%$269.82m
AZNAstraZeneca PLC Sponsored ADR
-0.41%37.411.3%$130.57m
NVSNovartis AG Sponsored ADR
-0.40%84.790.2%$110.37m
GSKGlaxoSmithKline plc Sponsored ADR
0.29%39.330.2%$73.09m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.37%47.470.1%$52.55m
SNYSanofi Sponsored ADR
-0.22%43.660.2%$44.04m
LCILannett Company, Inc.
-2.04%4.8037.0%$15.48m
AKTXAkari Therapeutics Plc Sponsored ADR
-0.98%2.021.7%$0.13m
EPIXESSA Pharma Inc
-6.12%3.070.1%$0.05m

Company Profile

scPharmaceuticals, Inc.engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include furosemide, used as parenteral diuretic in treating heart failure and ceftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Pitt Bertram in February 2013 and is headquartered in Burlington, MA.